Inspired green synthesis of metallic nanoparticles is evolving as an important branch of nanotechnology. Traditionally these are manufactured by wet chemical methods which require toxic and flammable chemicals. We report for the first time an economic and eco-friendly green synthesis of silver nanoparticles using Strychnos potatorum aqueous leaf extract from 3 mM silver nitrate solution. Nanoparticles thus formed are confirmed and characterized by using UV–Vis absorption spectroscopy, SEM and XRD measurements. The XRD and SEM analysis showed the average particle size of nanoparticles as 28 nm as well as revealed their (mixed, i.e., cubic and hexagonal) structure. Further, these green synthesized nanoparticles showed bactericidal activity against multidrug-resistant human pathogenic bacteria.

This study explores the green synthesis of silver nanoparticles (AgNPs) using Cymbopogon citratus (lemongrass) extract as a reducing agent. Synthesis was confirmed by a color change (light yellow to dark brown) under optimal conditions: 1.50 mM silver nitrate, 3.5% v/v extract, at 100 °C, with a pH of 9, and for 60 min. The AgNPs exhibited spherical morphology, a hydrodynamic diameter of 135.41 ± 49.30 nm, a zeta potential of −29.9 ± 1.4 mV, crystalline structure, and minimal aggregation. AgNPs showed significant antibacterial activity, particularly at >20 µg/well, with the zones of inhibition varying by bacterial strain. In vitro studies demonstrated anti-inflammatory, antidiabetic (α-glucosidase and α-amylase inhibition), and antioxidant activities, with AgNPs outperforming plant extract and nearing standard efficacy at higher concentrations. Cyto-toxicity studies indicated that AgNPs and plant extract were less toxic than doxorubicin but exhibited concentration-dependent effects on cancerous and non-cancerous cells. Eco-toxicity assays revealed that AgNPs were less acutely toxic than controls but posed risks with prolonged exposure. This work highlights the eco-friendly synthesis of AgNPs and their potential in biomedical applications, demonstrating efficacy in antibacterial and antioxidant activities.

Clinical research is a systematic process of conducting research work to find solutions for human health-related problems. It is applied to understand the disease process and assist in the diagnosis, treatment, and prevention. Currently, we are experiencing global unrest caused by the coronavirus disease (COVID-19) pandemic. The novel severe acute respiratory syndrome coronavirus (SARS-CoV-2) has been responsible for the deaths of more than 50 million people worldwide. Also, it has resulted in severe morbidity among the affected population. The cause of such a huge amount of influence on human health by the pandemic was the unavailability of drugs and therapeutic interventions to treat and manage the disease. Cancer is a disease condition wherein the normal cell function is deranged, and the cells multiply in an uncontrolled manner. Based on recent reports by the World Health Organization (WHO), cancer is the second leading cause of death globally. Moreover, the rates of cancers have shown an increasing trend in the past decade. Therefore, it is essential to improve the understanding concerning clinical research to address the health concerns of humans. In this review, we comprehensively discuss critical aspects of clinical research that include the research question, research objectives, patient-reported outcome measures (PROMs), intention-to-treat and per-protocol analysis, and endpoints in clinical and oncological research.

Because of the frequent emergence of novel microbial species and the re-emergence of genetic variants of hitherto known microbes, the global healthcare system, and human health has been thrown into jeopardy. Also, certain microbes that possess the ability to develop multi-drug resistance (MDR) have limited the treatment options in cases of serious infections, and increased hospital and treatment costs, and associated morbidity and mortality. The recent discovery of the novel Coronavirus (n-CoV), the Severe Acute Respiratory Syndrome CoV-2 (SARS-CoV-2) that is causing the CoV Disease-19 (COVID-19) has resulted in severe morbidity and mortality throughout the world affecting normal human lives. The major concern with the current pandemic is the non-availability of specific drugs and an incomplete understanding of the pathobiology of the virus. It is therefore important for pharmaceutical establishments to envisage the discovery of therapeutic interventions and potential vaccines against the novel and MDR microbes. Therefore, this review is attempted to update and explore the current perspectives in microbes, clinical research, drug discovery, and vaccine development to effectively combat the emerging novel and re-emerging genetic variants of microbes.

This study investigates the catalytic potential of silver nanoparticles (AgNPs) synthesized using aqueous Cymbopogon citratus (lemongrass) extract for the degradation of toxic textile dyes, offering an eco-friendly solution to industrial wastewater treatment. The green-synthesized AgNPs demonstrated remarkable degradation efficiency (>94%) for multiple dyes, such as rhodamine B, methyl red, methyl orange, methylene blue, eosin yellow, and Eriochrome black T, in the presence of sodium borohydride. Optimization studies employing a one-factor-at-a-time approach revealed the critical influence of AgNPs and reductant concentration, temperature, and pH. Kinetic analysis confirmed pseudo-first-order degradation behavior. Reactive species scavenging experiments established that hydroxyl radicals and holes played dominant roles in the degradation mechanism. Notably, the AgNPs retained catalytic activity across eight reuse cycles with negligible performance loss, demonstrating strong potential for repeated application. Comparative analysis with data from the literature highlights the superior performance of C. citratus-derived AgNPs in terms of reaction rate and efficiency. This work underscores the value of plant-extract-mediated AgNPs synthesis not only for its environmental compatibility but also for its catalytic effectiveness. The study advances the practical applicability of green nanotechnology in wastewater remediation and supports its integration into sustainable industrial practices.